In an extensive research paper featured in Nature Immunology, a recently discovered long non-coding RNA (lncRNA) called nuclear factor-κB (NF-κB)-interacting lncRNA (NKILA) was demonstrated to have a specific role in making anti-tumor T cells more susceptible to cell death upon stimulation by tumor-related antigens. Here, NFKB1 is linked to neoplasm.